Synbiotic Formula (SCV09) in Alzheimer's Disease Patients
Recruiting
N/A
Interventional Study
Alzheimer Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 60 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 30 (estimated)
- Sponsor
- Chinese University of Hong Kong · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In recent years, emerging studies have revealed the role of gut microbiota in human health and diseases, including AD and other neurodegenerative conditions5. Although the underlying mechanism is still largely unknown, successful therapies targeting the gut-brain axis may serve as indirect evidence of the possible linkage.
This pilot, single-arm study aims to estimate the efficacy and assess the …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Individuals aged between 60-85 with a clinical diagnosis of Alzheimer's disease
* Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) score of ≤20
* Neuropsychiatric Inventory-Questionnaire (NPI-12) ≥10
* Stable medication history for Alzheimer's disease within the pa…
Contacts